Dr. Chandra Kant Katiyar

Dr. chandra Kant Katiyar

Dr. Chandra Kant Katiyar

Advisor, Academic Research and a Mentor


  • Ph.D in Pharmacology and Neurology from Banaras Hindu University. 
  • M.D. (Ay.) from Banaras Hindu University.
  • BAMS from Rishikul Ayurvedic College, Haridwar. 
  • B.Sc from the University of Lucknow.


Ayurveda Researcher & Industry Expert.

Chandra Kant Katiyar is a distinguished Ayurveda Expert, renowned for his comprehensive expertise across various aspects of the field. Through affiliations with prestigious Ayurvedic institutes, he has significantly contributed to the advancement of Ayurveda. 

Dr. Katiyar has made notable contributions to the discovery of new drugs from medicinal plants. Additionally, he has played a significant role in ensuring the quality control of Ayurvedic and herbal drugs. This is evidenced by his membership in various committees, including the Ayurvedic Pharmacopoeia Committee, Herbal Committee for Indian Pharmacopoeia, and South East Asia Expert Panel on Dietary Supplements for United States Pharmacopoeia. Dr. Katiyar is highly regarded as a researcher, academician, and expert in regulatory policies for traditional medicines, including Ayurveda.



  • CEO, Health Care (Technical), Emami Ltd.
  • Director, Herbal Drug Research, Ranbaxy.
  • Vice President, Dabur India.
  • Member Of ASU Drugs Technical Advisory Board.
  • Reputed Researcher, Academician And Expert In Regulatory Policies For Traditional  Medicines Including Ayurveda. 
  •  Authored  Books Including ‘Ayurveda At The Turning Point’ and ‘Modern Ayurveda: Milestones Beyond the Classical Age’.   
  •  Made Significant Contributions In New Drug Discovery From Medicinal Plants. 



Dr. Chandra Kant Katiyar possesses remarkable expertise acquired over more than 30 years, uniquely blending the principles of Ayurveda with modern medicine. Dr. Chandra Kant Katiyar has also contributed significantly to academic literature through various research papers, notably including ‘Validation of Medicinal Herbs for Anti-tyrosinase Potential,’ ‘Exploration of the Gastroprotective and Digestive Potential of an Ayurvedic Asava–Arishta Preparation,’ and ‘Analysis of Government Policies and Initiatives for the Development of Ayurveda.’

Areas Of Expertise

  •  Clinical Research.
  • Pharmacological Studies.
  • Toxicological Evaluation of Herbal Drugs.
  • Regulatory And IPR policies.